PSYKOLOGERNE AARS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.1% 4.7% 5.3% 7.7% 7.1%  
Credit score (0-100)  44 45 40 31 33  
Credit rating  BBB BBB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  630 642 669 954 1,268  
EBITDA  75.0 140 -4.8 94.9 -37.5  
EBIT  75.0 140 -4.8 93.6 -38.9  
Pre-tax profit (PTP)  74.6 137.7 -7.9 92.3 -38.0  
Net earnings  58.1 107.4 -6.4 68.0 -31.0  
Pre-tax profit without non-rec. items  74.6 138 -7.9 92.3 -38.0  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  21.9 21.9 21.9 20.6 19.1  
Shareholders equity total  270 377 258 211 180  
Interest-bearing liabilities  0.1 0.1 0.1 0.1 20.8  
Balance sheet total (assets)  404 514 345 333 298  

Net Debt  -213 -420 -244 -171 -113  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  630 642 669 954 1,268  
Gross profit growth  0.2% 1.9% 4.2% 42.6% 32.9%  
Employees  1 1 1 2 2  
Employee growth %  0.0% 0.0% 0.0% 100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  404 514 345 333 298  
Balance sheet change%  26.2% 27.3% -32.8% -3.5% -10.6%  
Added value  75.0 139.8 -4.8 93.6 -37.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 -3 -3  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 -1.0 1.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  11.9% 21.8% -0.7% 9.8% -3.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  20.7% 30.5% -1.1% 27.6% -11.8%  
ROI %  30.9% 42.6% -1.5% 39.3% -17.8%  
ROE %  24.1% 33.2% -2.0% 29.0% -15.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  66.7% 73.3% 74.6% 63.4% 60.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -283.6% -300.7% 5,115.3% -180.3% 300.7%  
Gearing %  0.0% 0.0% 0.0% 0.0% 11.5%  
Net interest  0 0 0 0 0  
Financing costs %  1,165.0% 2,676.3% 3,971.3% 1,691.3% 8.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.8 3.6 3.6 2.5 2.2  
Current Ratio  2.8 3.6 3.6 2.5 2.2  
Cash and cash equivalent  212.9 420.6 244.1 171.2 133.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  231.6 339.0 218.0 174.3 140.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  75 140 -5 47 -19  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  75 140 -5 47 -19  
EBIT / employee  75 140 -5 47 -19  
Net earnings / employee  58 107 -6 34 -15